Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Blood Reviews|June 16, 2020
Current and future therapies for myelofibrosisSamir Asher, Donal P McLornan, Claire N HarrisonEjhaem|June 18, 2025
Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR studyDipal Mehta, Robert Cicero, Laura Chiecchio, et al.Ejhaem|October 17, 2024
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experienceDario Melotti, Samir Asher, Ethan Troy-Barnes, et al.Leukemia & Lymphoma|June 1, 2023
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experienceGeorge Nesr, Raakhee Shah, Charalampia Kyriakou, et al.Ejhaem|May 1, 2025
Belantamab Mafodotin Monotherapy for Multiply-Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of IrelandEdmund C R Watson, Faouzi Djebbari, Fotios Panitsas, et al.BMJ Open|November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trialKara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.Pageof 1